510(k) K934178
K934178 is an FDA 510(k) premarket notification submitted by Neometrics, Inc. for the device "ACCUSCREEN 17-HYDROXYPROGESTERONE". The FDA issued a decision of Substantially Equivalent on Mar 30, 1995. The device falls under product code JLX (Radioimmunoassay, 17-Hydroxyprogesterone), a Class I device regulated under 21 CFR 862.1395. Neometrics, Inc. has 20 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Mar 30, 1995
- Date Received
- Aug 27, 1993
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Radioimmunoassay, 17-Hydroxyprogesterone
- Device Class
- Class I
- Regulation Number
- 862.1395
- Review Panel
- CH
- Submission Type
- 510(k) Exempt
Need the full FDA record for Neometrics, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.